S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:PDEX

Pro-Dex (PDEX) Stock Price, News & Analysis

$17.55
+0.14 (+0.80%)
(As of 03/28/2024 ET)
Today's Range
$17.41
$17.71
50-Day Range
$16.50
$22.50
52-Week Range
$14.51
$22.99
Volume
2,303 shs
Average Volume
8,390 shs
Market Capitalization
$61.60 million
P/E Ratio
23.40
Dividend Yield
N/A
Price Target
N/A
PDEX stock logo

About Pro-Dex Stock (NASDAQ:PDEX)

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

PDEX Stock Price History

PDEX Stock News Headlines

Monogram Orthopaedics reports FY results
[BUY ALERT] Our #1 A.I. Stock for March
It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.
[BUY ALERT] Our #1 A.I. Stock for March
It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.
Pro-Dex Inc PDEX
Pro-Dex, Inc. Announces Fiscal 2024 First Quarter Results
North American Morning Briefing: S&P 500 Futures -2-
Pro-Dex's (NASDAQ:PDEX) Returns Have Hit A Wall
PDEX Pro-Dex, Inc.
See More Headlines
Receive PDEX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/08/2024
Today
3/28/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:PDEX
Employees
145
Year Founded
N/A

Profitability

Net Income
$7.07 million
Pretax Margin
8.28%

Debt

Sales & Book Value

Annual Sales
$46.09 million
Cash Flow
$2.29 per share
Book Value
$8.91 per share

Miscellaneous

Free Float
2,015,000
Market Cap
$61.78 million
Optionable
Not Optionable
Beta
0.60
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

PDEX Stock Analysis - Frequently Asked Questions

How have PDEX shares performed in 2024?

Pro-Dex's stock was trading at $17.52 at the start of the year. Since then, PDEX stock has increased by 0.2% and is now trading at $17.55.
View the best growth stocks for 2024 here
.

Are investors shorting Pro-Dex?

Pro-Dex saw a increase in short interest in March. As of March 15th, there was short interest totaling 18,600 shares, an increase of 34.8% from the February 29th total of 13,800 shares. Based on an average trading volume of 8,200 shares, the short-interest ratio is currently 2.3 days. Currently, 0.8% of the shares of the stock are short sold.
View Pro-Dex's Short Interest
.

When is Pro-Dex's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our PDEX earnings forecast
.

How were Pro-Dex's earnings last quarter?

Pro-Dex, Inc. (NASDAQ:PDEX) released its quarterly earnings data on Thursday, February, 8th. The medical instruments supplier reported $0.14 earnings per share (EPS) for the quarter. The medical instruments supplier had revenue of $12.59 million for the quarter. Pro-Dex had a trailing twelve-month return on equity of 8.97% and a net margin of 5.59%.

What is Michael J. Berthelot's approval rating as Pro-Dex's CEO?

3 employees have rated Pro-Dex Chief Executive Officer Michael J. Berthelot on Glassdoor.com. Michael J. Berthelot has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Pro-Dex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pro-Dex investors own include KEMET (KEM), NVIDIA (NVDA), Enterprise Products Partners (EPD), Micron Technology (MU), AT&T (T), AbbVie (ABBV), Alibaba Group (BABA), Bank of America (BAC), Marvell Technology (MRVL) and UnitedHealth Group (UNH).

Who are Pro-Dex's major shareholders?

Pro-Dex's stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (3.52%), Vanguard Group Inc. (3.52%), Northern Trust Corp (0.74%), LSV Asset Management (0.73%) and Perritt Capital Management Inc. (0.12%). Insiders that own company stock include Alisha Charlton, Katrina Marie Kramer Philp and William James Farrell III.
View institutional ownership trends
.

How do I buy shares of Pro-Dex?

Shares of PDEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PDEX) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners